Morgan Stanley’s Counterpoint Global eyes potential of psychedelics
Morgan Stanley's Counterpoint Global team, a collective of investors and researchers, has turned its focus to the potential of psychedelics.…
Senate Committee on Appropriations directs medical marijuana Access for vets
The Senate Committee on Appropriations has recently issued directives that could potentially revolutionize the medical industry. These directives focus on…
Pennsylvania Senator John Fetterman advocates for psilocybin mushrooms
Pennsylvania Senator Governor John Fetterman recently spoke out in support of psilocybin mushrooms as a potential mental health treatment and…
Morgan Stanley report highlights potential of psychedelic drugs in mental health treatment
Morgan Stanley, one of the world's leading investment banks, has published a report on the potential of psychedelic drugs in…
NIDA announces $1.5 million in funding for psychedelic addiction research
The National Institute on Drug Abuse (NIDA) has announced $1.5 million in funding for research on the use of psychedelics…
